NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
CytoDyn, Inc.
ImCheck Therapeutics
Domain Therapeutics SA
Institut Curie
Center Eugene Marquis
OSE Immunotherapeutics
Institut Curie
Tomsk National Research Medical Center of the Russian Academy of Sciences